Nonocclusive mesenteric ischemia in patients with methamphetamine use

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

BACKGROUND Data suggest that methamphetamine may increase the risk of nonocclusive mesenteric ischemia (NOMI). We describe patterns of presentation and outcomes of patients with methamphetamine use who present with NOMI to a single institution. METHODS This is an observational study of patients from January 2015 to September 2017 with methamphetamine use who presented with NOMI at an academic medical center in Northern California. We summarize patient comorbidities, clinical presentation, operative findings, pathologic findings, hospital course, and survival. RESULTS Ten patients with methamphetamine use and severe NOMI were identified. One patient was readmitted with a perforated duodenal ulcer, for a total of 11 encounters. Most presented with acute (n = 3) or acute-on-chronic (n = 4) abdominal pain. Distribution of ischemia ranged from perforated duodenal ulcer (n = 3), ischemia of the distal ileum (n = 1), ischemia of entire small bowel (n = 2), and patchy necrosis of entire small bowel and colon (n = 5). Six patients died, three within 1 week of admission and three between 3 months and 8 months. CONCLUSION Methamphetamine use may be associated with significant microvascular compromise, increasing the risk of mesenteric ischemia. Providers in areas with high prevalence of methamphetamine use should have a high index of suspicion for intestinal ischemia in this patient population. Patients with methamphetamine use admitted for trauma or other pathology may be at particular risk of ischemia and septic shock, especially in the setting of dehydration. Use of vasoconstrictors in this patient population may also exacerbate intestinal ischemia. LEVEL OF EVIDENCE Therapeutic Case series study, level V.

Original languageEnglish (US)
Pages (from-to)885-892
Number of pages8
JournalJournal of Trauma and Acute Care Surgery
Volume84
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Methamphetamine
Ischemia
Duodenal Ulcer
Mesenteric Ischemia
Vasoconstrictor Agents
Septic Shock
Ileum
Dehydration
Abdominal Pain
Population
Observational Studies
Comorbidity
Colon
Necrosis
Pathology
Survival
Wounds and Injuries

Keywords

  • Mesenteric ischemia
  • methamphetamine
  • NOMI
  • nonocclusive mesenteric ischemia
  • substance abuse

ASJC Scopus subject areas

  • Surgery
  • Critical Care and Intensive Care Medicine

Cite this

Nonocclusive mesenteric ischemia in patients with methamphetamine use. / Anderson, Jamie; Brown, Ian Elliott; Olson, Kristin A; Iverson, Katherine; Cocanour, Christine S; Galante, Joseph M.

In: Journal of Trauma and Acute Care Surgery, Vol. 84, No. 6, 01.06.2018, p. 885-892.

Research output: Contribution to journalArticle

@article{4dc3dc7280e9422c9b05f8bd4e89f399,
title = "Nonocclusive mesenteric ischemia in patients with methamphetamine use",
abstract = "BACKGROUND Data suggest that methamphetamine may increase the risk of nonocclusive mesenteric ischemia (NOMI). We describe patterns of presentation and outcomes of patients with methamphetamine use who present with NOMI to a single institution. METHODS This is an observational study of patients from January 2015 to September 2017 with methamphetamine use who presented with NOMI at an academic medical center in Northern California. We summarize patient comorbidities, clinical presentation, operative findings, pathologic findings, hospital course, and survival. RESULTS Ten patients with methamphetamine use and severe NOMI were identified. One patient was readmitted with a perforated duodenal ulcer, for a total of 11 encounters. Most presented with acute (n = 3) or acute-on-chronic (n = 4) abdominal pain. Distribution of ischemia ranged from perforated duodenal ulcer (n = 3), ischemia of the distal ileum (n = 1), ischemia of entire small bowel (n = 2), and patchy necrosis of entire small bowel and colon (n = 5). Six patients died, three within 1 week of admission and three between 3 months and 8 months. CONCLUSION Methamphetamine use may be associated with significant microvascular compromise, increasing the risk of mesenteric ischemia. Providers in areas with high prevalence of methamphetamine use should have a high index of suspicion for intestinal ischemia in this patient population. Patients with methamphetamine use admitted for trauma or other pathology may be at particular risk of ischemia and septic shock, especially in the setting of dehydration. Use of vasoconstrictors in this patient population may also exacerbate intestinal ischemia. LEVEL OF EVIDENCE Therapeutic Case series study, level V.",
keywords = "Mesenteric ischemia, methamphetamine, NOMI, nonocclusive mesenteric ischemia, substance abuse",
author = "Jamie Anderson and Brown, {Ian Elliott} and Olson, {Kristin A} and Katherine Iverson and Cocanour, {Christine S} and Galante, {Joseph M}",
year = "2018",
month = "6",
day = "1",
doi = "10.1097/TA.0000000000001855",
language = "English (US)",
volume = "84",
pages = "885--892",
journal = "Journal of Trauma and Acute Care Surgery",
issn = "2163-0755",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Nonocclusive mesenteric ischemia in patients with methamphetamine use

AU - Anderson, Jamie

AU - Brown, Ian Elliott

AU - Olson, Kristin A

AU - Iverson, Katherine

AU - Cocanour, Christine S

AU - Galante, Joseph M

PY - 2018/6/1

Y1 - 2018/6/1

N2 - BACKGROUND Data suggest that methamphetamine may increase the risk of nonocclusive mesenteric ischemia (NOMI). We describe patterns of presentation and outcomes of patients with methamphetamine use who present with NOMI to a single institution. METHODS This is an observational study of patients from January 2015 to September 2017 with methamphetamine use who presented with NOMI at an academic medical center in Northern California. We summarize patient comorbidities, clinical presentation, operative findings, pathologic findings, hospital course, and survival. RESULTS Ten patients with methamphetamine use and severe NOMI were identified. One patient was readmitted with a perforated duodenal ulcer, for a total of 11 encounters. Most presented with acute (n = 3) or acute-on-chronic (n = 4) abdominal pain. Distribution of ischemia ranged from perforated duodenal ulcer (n = 3), ischemia of the distal ileum (n = 1), ischemia of entire small bowel (n = 2), and patchy necrosis of entire small bowel and colon (n = 5). Six patients died, three within 1 week of admission and three between 3 months and 8 months. CONCLUSION Methamphetamine use may be associated with significant microvascular compromise, increasing the risk of mesenteric ischemia. Providers in areas with high prevalence of methamphetamine use should have a high index of suspicion for intestinal ischemia in this patient population. Patients with methamphetamine use admitted for trauma or other pathology may be at particular risk of ischemia and septic shock, especially in the setting of dehydration. Use of vasoconstrictors in this patient population may also exacerbate intestinal ischemia. LEVEL OF EVIDENCE Therapeutic Case series study, level V.

AB - BACKGROUND Data suggest that methamphetamine may increase the risk of nonocclusive mesenteric ischemia (NOMI). We describe patterns of presentation and outcomes of patients with methamphetamine use who present with NOMI to a single institution. METHODS This is an observational study of patients from January 2015 to September 2017 with methamphetamine use who presented with NOMI at an academic medical center in Northern California. We summarize patient comorbidities, clinical presentation, operative findings, pathologic findings, hospital course, and survival. RESULTS Ten patients with methamphetamine use and severe NOMI were identified. One patient was readmitted with a perforated duodenal ulcer, for a total of 11 encounters. Most presented with acute (n = 3) or acute-on-chronic (n = 4) abdominal pain. Distribution of ischemia ranged from perforated duodenal ulcer (n = 3), ischemia of the distal ileum (n = 1), ischemia of entire small bowel (n = 2), and patchy necrosis of entire small bowel and colon (n = 5). Six patients died, three within 1 week of admission and three between 3 months and 8 months. CONCLUSION Methamphetamine use may be associated with significant microvascular compromise, increasing the risk of mesenteric ischemia. Providers in areas with high prevalence of methamphetamine use should have a high index of suspicion for intestinal ischemia in this patient population. Patients with methamphetamine use admitted for trauma or other pathology may be at particular risk of ischemia and septic shock, especially in the setting of dehydration. Use of vasoconstrictors in this patient population may also exacerbate intestinal ischemia. LEVEL OF EVIDENCE Therapeutic Case series study, level V.

KW - Mesenteric ischemia

KW - methamphetamine

KW - NOMI

KW - nonocclusive mesenteric ischemia

KW - substance abuse

UR - http://www.scopus.com/inward/record.url?scp=85048026123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048026123&partnerID=8YFLogxK

U2 - 10.1097/TA.0000000000001855

DO - 10.1097/TA.0000000000001855

M3 - Article

C2 - 29462085

AN - SCOPUS:85048026123

VL - 84

SP - 885

EP - 892

JO - Journal of Trauma and Acute Care Surgery

JF - Journal of Trauma and Acute Care Surgery

SN - 2163-0755

IS - 6

ER -